AyurMaya Capital Management Company, LP - 01 Jul 2024 Form 4 Insider Report for ALUMIS INC. (ALMS)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
03 Jul 2024, 16:45:38 UTC
Prior SEC filing
27 Jun 2024
Next SEC filing
23 May 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
AyurMaya Capital Management Company, LP, By AyurMaya Capital Management Company GP, LLC, Its General Partner, By: /s/ David E. Goel, Managing Member

Key filing fact

AyurMaya Capital Management Company, LP filed Form 4 for ALUMIS INC. (ALMS) on 03 Jul 2024.

Key facts

  • This page summarizes AyurMaya Capital Management Company, LP's Form 4 filing for ALUMIS INC. (ALMS).
  • 5 reported transactions and 3 derivative rows are listed below.
  • Accepted by SEC: 03 Jul 2024, 16:45.

Change

  • Previous filing in this sequence was filed on 27 Jun 2024.
  • Current net transaction value: +$40,000,000.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

NASDAQ transaction

Common Stock, par value $0.0001 per share ("Common Stock")

Conversion of derivative security

Transaction value
Shares
+8,145,966
Change %
Price
Shares after
8,145,966
Date
01 Jul 2024
Ownership
See footnotes
Footnotes
F1, F2, F3, F4
NASDAQ transaction

Common Stock

Award

Transaction value
$40,000,000
Shares
+2,500,000
Change %
+31%
Price
$16.00*
Shares after
10,645,966
Date
01 Jul 2024
Ownership
See footnotes
Footnotes
F3, F4

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

NASDAQ transaction Derivative

Series B Redeemable Convertible Preferred Stock

Conversion of derivative security

Transaction value
$0
Shares
-20,000,000
Change %
-100%
Price
$0.000000*
Shares after
0
Date
01 Jul 2024
Ownership
See footnotes
Underlying class
Common Stock
Underlying amount
4,278,074
Exercise price
Footnotes
F1, F2, F3, F4
NASDAQ transaction Derivative

Series B-2 Redeemable Convertible Preferred Stock

Conversion of derivative security

Transaction value
$0
Shares
-5,336,489
Change %
-100%
Price
$0.000000*
Shares after
0
Date
01 Jul 2024
Ownership
See footnotes
Underlying class
Common Stock
Underlying amount
1,141,494
Exercise price
Footnotes
F1, F2, F3, F4
NASDAQ transaction Derivative

Series C Redeemable Convertible Preferred Stock

Conversion of derivative security

Transaction value
$0
Shares
-12,745,916
Change %
-100%
Price
$0.000000*
Shares after
0
Date
01 Jul 2024
Ownership
See footnotes
Underlying class
Common Stock
Underlying amount
2,726,398
Exercise price
Footnotes
F1, F2, F3, F4
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

Each share of preferred stock is convertible at any time, at the holder's election, into shares of Class A Common Stock on a 4.675-to-one basis (on an adjusted basis, after giving effect to the reverse stock split of the Class A Common Stock effected by the Issuer on June 20, 2024) and has no expiration date. Immediately prior to the completion of the Issuer's initial public offering of voting common stock (the "Common Stock") (the "IPO"), the shares of preferred stock reported herein automatically converted into the number of shares of Class A Common Stock in column 3.

Footnote F2

Each share of Class A Common Stock was reclassified into one share of Common Stock immediately prior to the completion of the IPO.

Footnote F3

The securities reported herein are held by AyurMaya Capital Management Fund, LP (the "AyurMaya Fund"). AyurMaya Capital Management Company, LP (the "Investment Manager"), a Delaware limited partnership, is the investment advisor to the AyurMaya Fund. Mr. David E. Goel ("Mr. Goel", and together with the Investment Manager, the "Reporting Persons"), serves as the managing member of AyurMaya Capital Management Company GP, LLC, the general partner of the Investment Manager.

Footnote F4

The filing of this statement shall not be deemed an admission that either of the Reporting Persons is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Act of 1934, as amended, or otherwise. Each of the Reporting Persons expressly disclaims beneficial ownership of the securities reported herein except to the extent of its or his pecuniary interest therein.

SEC remarks

The Investment Manager may be deemed to be a director by deputization for purposes of Section 16 under the Securities Exchange Act of 1934 by virtue of the fact that Mr. Alan Colowick, Senior Managing Director of Matrix Capital Management Company LP, an affiliate of the Investment Manager, currently serves on the board of directors of the Issuer.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .